These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 9612536

  • 1. Venlafaxine withdrawal syndrome.
    Macbeth R, Rajagopalan M.
    Aust N Z J Med; 1998 Apr; 28(2):218. PubMed ID: 9612536
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Possible venlafaxine withdrawal syndrome.
    Farah A, Lauer TE.
    Am J Psychiatry; 1996 Apr; 153(4):576. PubMed ID: 8599410
    [No Abstract] [Full Text] [Related]

  • 4. Withdrawal syndrome after discontinuation of venlafaxine.
    Agelink MW, Zitzelsberger A, Klieser E.
    Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of venlafaxine discontinuation symptoms with ondansetron.
    Raby WN.
    J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
    Luckhaus C, Jacob C.
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):43-4. PubMed ID: 11343628
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Withdrawal reactions associated with venlafaxine.
    Parker G, Blennerhassett J.
    Aust N Z J Psychiatry; 1998 Apr; 32(2):291-4. PubMed ID: 9588310
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
    Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF.
    Am J Psychiatry; 1997 Dec; 154(12):1760-2. PubMed ID: 9396960
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Venlafaxine-induced delirium.
    Howe C, Ravasia S.
    Can J Psychiatry; 2003 Mar; 48(2):129. PubMed ID: 12655917
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.